Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.795
-0.115 (-6.02%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Rein Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 12.87 | 17.31 | 5.19 | 3.6 | 7.05 | Upgrade
|
| Short-Term Investments | - | - | 16.05 | 42.33 | 6.76 | Upgrade
|
| Cash & Short-Term Investments | 12.87 | 17.31 | 21.24 | 45.93 | 13.81 | Upgrade
|
| Cash Growth | -25.69% | -18.50% | -53.75% | 232.73% | -24.47% | Upgrade
|
| Prepaid Expenses | - | - | 0.61 | 2.22 | 1.93 | Upgrade
|
| Restricted Cash | - | 0.03 | 0.03 | 0.03 | 0.59 | Upgrade
|
| Other Current Assets | 0.79 | 0.93 | - | - | - | Upgrade
|
| Total Current Assets | 13.66 | 18.27 | 21.87 | 48.18 | 16.33 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.02 | 0.11 | 0.28 | 0.02 | Upgrade
|
| Goodwill | 6.33 | 6.33 | - | - | - | Upgrade
|
| Other Intangible Assets | 42.2 | 79.2 | - | - | - | Upgrade
|
| Long-Term Deferred Charges | - | 2.14 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0 | 0.05 | 0.02 | 0.02 | - | Upgrade
|
| Total Assets | 62.19 | 106.01 | 22.01 | 48.48 | 16.34 | Upgrade
|
| Accounts Payable | 0.91 | 1.19 | 1.72 | 1.21 | 1.6 | Upgrade
|
| Accrued Expenses | 4.72 | 2.94 | 1.45 | 3.15 | 1.95 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.17 | Upgrade
|
| Current Portion of Leases | - | 0.05 | 0.03 | 0.09 | - | Upgrade
|
| Other Current Liabilities | 0.12 | 0.21 | 0.18 | 0.06 | 0.24 | Upgrade
|
| Total Current Liabilities | 5.75 | 4.39 | 3.38 | 4.51 | 3.96 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.22 | Upgrade
|
| Long-Term Leases | - | - | - | 0.07 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.77 | 3.33 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.28 | - | - | - | - | Upgrade
|
| Total Liabilities | 7.8 | 7.71 | 3.38 | 4.58 | 4.18 | Upgrade
|
| Common Stock | 0.11 | 0.09 | 0.09 | 0.09 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 360.7 | 295.38 | 291.37 | 289.28 | 231.41 | Upgrade
|
| Retained Earnings | -351.4 | -288.52 | -272.79 | -245.46 | -219.29 | Upgrade
|
| Comprehensive Income & Other | -0.02 | -0.06 | -0.05 | -0.01 | -0 | Upgrade
|
| Total Common Equity | 9.39 | 6.89 | 18.62 | 43.9 | 12.16 | Upgrade
|
| Shareholders' Equity | 54.39 | 98.3 | 18.62 | 43.9 | 12.16 | Upgrade
|
| Total Liabilities & Equity | 62.19 | 106.01 | 22.01 | 48.48 | 16.34 | Upgrade
|
| Total Debt | - | 0.05 | 0.03 | 0.16 | 0.39 | Upgrade
|
| Net Cash (Debt) | 12.87 | 17.27 | 21.21 | 45.77 | 13.42 | Upgrade
|
| Net Cash Growth | -25.49% | -18.60% | -53.66% | 241.12% | 1.30% | Upgrade
|
| Net Cash Per Share | 0.72 | 3.75 | 4.67 | 10.31 | 7.70 | Upgrade
|
| Filing Date Shares Outstanding | 21.99 | 16.97 | 4.54 | 4.53 | 4.51 | Upgrade
|
| Total Common Shares Outstanding | 21.67 | 4.89 | 4.54 | 4.53 | 2.19 | Upgrade
|
| Working Capital | 7.91 | 13.88 | 18.49 | 43.67 | 12.37 | Upgrade
|
| Book Value Per Share | 0.43 | 1.41 | 4.10 | 9.69 | 5.55 | Upgrade
|
| Tangible Book Value | -39.14 | -78.64 | 18.62 | 43.9 | 12.16 | Upgrade
|
| Tangible Book Value Per Share | -1.81 | -16.10 | 4.10 | 9.69 | 5.55 | Upgrade
|
| Machinery | - | - | 0.34 | 0.34 | - | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.